5 Compelling Reasons Why AbbVie's Dividend Will Keep on Growing

What's the best dividend stock in all of big pharma? I would argue that the hands-down winner is AbbVie (NYSE: ABBV). The big biotech has the total package for dividend-seeking investors: a high yield, manageable payout ratio, and a long record of dividend increases.

I listened to several members of AbbVie's executive team, including CEO Rick Gonzalez, talk about their company's future at the Morgan Stanley healthcare conference on Tuesday. It was an interesting discussion. One of the biggest takeaways I had as someone who regularly covers AbbVie is this: The dividend will keep on growing. Here are five reasons why.

Image source: Getty Images.

Source: Fool.com

Amgen Inc. Aktie

Leicht abwärts geht es heute für die Amgen Inc. Aktie. Seit gestern notiert das Papier um -0,25 % tiefer.
Mit 28 Buy-Einschätzungen und keiner einzigen Sell-Einschätzung ist Amgen Inc. einer der Lieblinge unserere Community.
Das Kursziel von 304 € für Amgen Inc. weist auf eine leichte Verbesserung gegenüber dem aktuellen Kurs von 297.4 € hin.

Like: 0

AMGN

Teilen